Molecule data - Company finances
|
EUR
|
2022
From: 2022-01-05
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 5,790 | 10,328 | 12,955 | 13,358 |
| Profit before tax | - | - | - | - |
| Net profit | -19,062 | 2,292 | 6,496 | 7,741 |
| Equity | 938 | 3,230 | 9,726 | 17,467 |
| Liabilities | 1,081 | 2,031 | 1,390 | 1,760 |
| Non-current assets | 0 | 0 | 0 | 0 |
| Current assets | 2,009 | 5,261 | 11,116 | 19,227 |
| Total assets | 2,009 | 5,261 | 11,116 | 19,227 |
|
Taxes paid
|
||||
| STI taxes | - | 412 | 507 | 557 |
|
Financial indicators
|
||||
| Revenue change y/y | - | +78.4% | +25.4% | +3.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -948.8% | 43.6% | 58.4% | 40.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -2032.2% | 71.0% | 66.8% | 44.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -329.2% | 22.2% | 50.1% | 58.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.2 | 0.6 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 5,790 | 10,328 | 12,955 | 13,358 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Molecule data - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-06 | 0.02 |
| 2026-09-01 | 2026-09-02 | 0.02 |
| 2026-07-23 | 2026-07-26 | 0.02 |
| 2026-06-16 | 2026-07-12 | 2.57 |
| 2026-05-03 | 2026-05-12 | 0.05 |
| 2026-04-20 | 2026-04-29 | 0.05 |
| 2026-03-29 | 2026-04-14 | 0.05 |
| 2026-03-17 | 2026-03-27 | 0.05 |
| 2026-02-18 | 2026-03-09 | 0.05 |
| 2026-01-21 | 2026-02-16 | 0.05 |
| 2025-10-16 | 2025-10-21 | 31.54 |
| 2025-06-08 | 2025-06-08 | 0.01 |
| 2025-05-16 | 2025-06-04 | 0.01 |
| 2025-05-04 | 2025-05-12 | 0.01 |
| 2025-04-24 | 2025-04-29 | 0.01 |
| 2025-03-18 | 2025-03-25 | 5.55 |
| 2022-06-16 | 2022-07-14 | 0.01 |
| 2022-05-17 | 2022-06-12 | 0.01 |
| 2022-04-28 | 2022-05-05 | 0.01 |
| 2022-02-17 | 2022-02-17 | 14.84 |
Molecule data - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-01 | 2026-02-21 | 0.6 |
| 2025-11-28 | 2025-12-29 | 0.6 |
| 2025-09-28 | 2025-11-25 | 0.6 |
| 2025-06-27 | 2025-09-25 | 0.6 |
| 2025-06-21 | 2025-06-26 | 212.64 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Molecule data, UAB (company code 305971683) is a Private Limited Liability Company engaged in computing infrastructure, data processing, hosting and related activities. In 2025, the latest financial year, the company generated revenue of €13.4K and net profit of €7.7K, resulting in a profit margin of 58.0%. Revenue increased by 3.1% year on year and by 29.3% over two years, showing steady expansion from €10.3K in 2023 to €13.0K in 2024 and €13.4K in 2025. Profitability strengthened more quickly than revenue, rising from €2.3K in 2023 to €6.5K in 2024 and €7.7K in 2025. At the end of 2025, total assets stood at €19.2K, equity at €17.5K and liabilities at €1.8K. The balance sheet was strongly equity financed, with an equity ratio of 90.8% and debt-to-equity of 0.10. Return on equity was 44.3% and return on assets 40.3%, while asset turnover was 0.69x. Revenue per employee was €13.4K and profit per employee €7.7K.